{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:42:50Z","timestamp":1759408970219,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93703","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:26:59Z","timestamp":1759408019000},"source":"Crossref","is-referenced-by-count":0,"title":["Uncommon Origin, Common Presentation: A Rare Case of Mesenteric Carcinoid Tumor Mimicking Functional Gastrointestinal Disorders"],"prefix":"10.7759","author":[{"given":"Radhika","family":"Mathur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Borra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Muddassir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4174\/jkss.2013.84.2.114","article-title":"Primary mesenteric carcinoid tumor","volume":"84","author":"Park IS","year":"2013","unstructured":"Park IS, Kye BH, Kim HS, Kim HJ, Cho HM, Yoo C, Hwang SS. Primary mesenteric carcinoid tumor. J Korean Surg Soc. 2013, 84:114-7. 10.4174\/jkss.2013.84.2.114","journal-title":"J Korean Surg Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108517","article-title":"Primary mesenteric neuroendocrine tumor: case report","volume":"109","author":"Gonz\u00e1lez-Mu\u00f1oz A","year":"2023","unstructured":"Gonz\u00e1lez-Mu\u00f1oz A, Aguirre-Salamanca EJ, Rivera-Rinc\u00f3n NA, Rodr\u00edguez-Narvaez JG, Gonz\u00e1lez-Sierra P, Ram\u00edrez-Giraldo C. Primary mesenteric neuroendocrine tumor: case report. Int J Surg Case Rep. 2023, 109:108517. 10.1016\/j.ijscr.2023.108517","journal-title":"Int J Surg Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebaffd","article-title":"NANETS consensus guidelines for the diagnosis of neuroendocrine tumor","volume":"39","author":"Vinik AI","year":"2010","unstructured":"Vinik AI, Woltering EA, Warner RR, et al.. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010, 39:713-34. 10.1097\/MPA.0b013e3181ebaffd","journal-title":"Pancreas"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet J","year":"2015","unstructured":"Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015, 121:589-97. 10.1002\/cncr.29099","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0125","article-title":"Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel M","year":"2014","unstructured":"Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014, 21:R153-63. 10.1530\/ERC-13-0125","journal-title":"Endocr Relat Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.1535","article-title":"Chromogranin A: is it a useful marker of neuroendocrine tumors?","volume":"25","author":"Campana D","year":"2007","unstructured":"Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P. Chromogranin A: is it a useful marker of neuroendocrine tumors?. J Clin Oncol. 2007, 25:1967-73. 10.1200\/JCO.2006.10.1535","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope TA","year":"2018","unstructured":"Hope TA, Bergsland EK, Bozkurt MF, et al.. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nucl Med. 2018, 59:66-74. 10.2967\/jnumed.117.202275","journal-title":"J Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al.. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020, 76:182-8. 10.1111\/his.13975","journal-title":"Histopathology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel M","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020, 31:844-60. 10.1016\/j.annonc.2020.03.304","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg J","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, et al.. Phase 3 trial of (177)Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017, 376:125-35. 10.1056\/NEJMoa1607427","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184438","article-title":"Management of small bowel neuroendocrine tumours: 10 years' experience at a tertiary referral centre","volume":"15","author":"Clift AK","year":"2023","unstructured":"Clift AK, Drymousis P, von Roon A, et al.. Management of small bowel neuroendocrine tumours: 10 years' experience at a tertiary referral centre. Cancers (Basel). 2023, 15:10.3390\/cancers15184438","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-9485.2009.02031.x","article-title":"Radiopathological review of small bowel carcinoid tumours","volume":"53","author":"Wong M","year":"2009","unstructured":"Wong M, Kong A, Constantine S, et al.. Radiopathological review of small bowel carcinoid tumours. J Med Imaging Radiat Oncol. 2009, 53:1-12. 10.1111\/j.1754-9485.2009.02031.x","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref13","article-title":"Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?","volume":"14","author":"Vardareli E","year":"2003","unstructured":"Vardareli E, Sari\u00e7am T, I\u015fiksoy S, Yavuz H, Ozakyol A, Kircali B. Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?. Turk J Gastroenterol. 2003, 14:194-6.","journal-title":"Turk J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.5012","article-title":"Management of advanced gastroenteropancreatic neuroendocrine and adrenal tumors","volume":"23 (Supplement)","author":"Bergsland EK","year":"2025","unstructured":"Bergsland EK. Management of advanced gastroenteropancreatic neuroendocrine and adrenal tumors.  J Natl Compr Canc Netw. 2025, 23 (Supplement):e255012. 10.6004\/jnccn.2025.5012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3","volume":"35","author":"Panzuto F","year":"2023","unstructured":"Panzuto F, Ramage J, Pritchard DM, et al.. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J Neuroendocrinol. 2023, 35:e13306. 10.1111\/jne.13306","journal-title":"J Neuroendocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/410983-uncommon-origin-common-presentation-a-rare-case-of-mesenteric-carcinoid-tumor-mimicking-functional-gastrointestinal-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:26:59Z","timestamp":1759408019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/410983-uncommon-origin-common-presentation-a-rare-case-of-mesenteric-carcinoid-tumor-mimicking-functional-gastrointestinal-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.93703","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}